AQNEURSA
Live / Registered — Registered (as of 25 Feb 2025)
What this means for you
Registered since 25 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98104776
- Registration number
- 7707978
- Mark type
- Stylized text
- Filed
- 27 Jul 2023
- Published for opposition
- 07 May 2024
- Registered
- 25 Feb 2025
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for activating cellular function; pharmaceutical preparations for the prevention and treatment of diseases, disorders, or conditions of the nervous system; pharmaceutical preparations for treating sensory organ disorders; pharmaceutical preparations for treating nervous system injury or impairment; pharmaceutical preparations for use in the prevention and treatment of neurological and neurodegenerative diseases; drugs for medical purposes, namely, drugs for the prevention and treatment of neurological and neurodegenerative diseases
Owner
- INTRABIO INC., AUSTIN, TX, US
- IntraBio Ltd, London, GB
- IntraBio Ltd, London, GB
- IntraBio Ltd, London, GB
Prosecution history
- 30 Apr 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 25 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 04 Feb 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Feb 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Jan 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Sept 2024 — USE AMENDMENT FILED
- 30 Jan 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Dec 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Sept 2024 — TEAS STATEMENT OF USE RECEIVED
- 02 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 May 2024 — PUBLISHED FOR OPPOSITION
- 17 Apr 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Mar 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER